Effect of intravitreal ranibizumab on fibrovascular membranes in patients with proliferative diabetic retinopathy

被引:0
|
作者
Liang, Ze-Yu [1 ]
Wang, Yi-Peng [2 ]
Li, Jing [1 ]
Yang, Wen-Chao [2 ]
Tu, Yong-Fang [2 ]
Zhang, Yue [1 ]
Chen, Song [1 ]
机构
[1] Nankai Univ, Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci,Affiliated, Tianjin 300020, Peoples R China
[2] Anyang Eye Hosp, Anyang 455000, Henan, Peoples R China
关键词
  proliferative diabetic retinopathy; ranibizumab; fibrovascular membranes; glial-mesenchymal transition; microvessel density; ENDOTHELIAL-CELLS; MULLER GLIA; BEVACIZUMAB; EXPRESSION; MARKER; VEGF;
D O I
10.18240/ijo.2022.10.03
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
? AIM: To assess the effects of intravitreal ranibizumab (IVR) on angiogenesis and glial activity of the fibrovascular membrane (FVM) in patients with proliferative diabetic retinopathy (PDR).? METHODS: Forty-two eyes from 42 patients with PDR requiring vitrectomy were included and divided into two groups: control group (n=16) did not receive IVR, while IVR group (n=26) underwent IVR 5d before vitrectomy. FVM specimens were collected by the same surgeon during the interventions. Histopathological morphology was examined by hematoxylin-eosin (H-E) staining and cell densities in the FVM was assessed. Microvessels were outlined by immunohistochemical staining of CD31 and microvessel density (MVD) assessed as an index of FVM angiogenesis. Dual-color immunofluorescence staining, and confocal microscopy was used to detect co-localization and relative expression levels of glial fibrillary acidic protein (GFAP) and alpha-smooth muscle actin (alpha-SMA) as markers of glial-mesenchymal transition (GMT). The GMT index (GI; ratio of relative GFAP/alpha-SMA expression) was used to semi-quantify the degree of GMT or glial activity of FVMs.? RESULTS: H-E staining showed similar vascularization in both groups, with microvessels and scattered stromal cells in the matrix. Infiltrated cell densities did not differ significantly between the two groups (P>0.05). The MVD of the IVR group (130.62 +/- 15.46/mm2) was significantly lower than that of the controls (142.25 +/- 19.16/mm2, P<0.05). In both groups, all sections were strongly immunostained for GFAP and alpha-SMA. The Pearson's correlation coefficients (PCC) of intensity of automated pixel count of two markers indicated GFAP and alpha-SMA co-stained well and GMT participated in the remolding of FVMs in PDR. The mean relative GFAP expression in the IVR group was significantly lower, whereas that of alpha-SMA was significantly higher than in controls (P<0.05). GI in the IVR group (1.10 +/- 0.10) was significantly lower than in the controls (1.21 +/- 0.12, P<0.05).? CONCLUSION: IVR can reduce angiogenesis, glial activity of FVM and promote glial-fibrotic transformation by reducing MVD and promoting GMT but does not decrease the cell density in patients with PDR.
引用
收藏
页码:1577 / 1585
页数:9
相关论文
共 50 条
  • [11] Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy
    Salzmann, J
    Limb, GA
    Khaw, PT
    Gregor, ZJ
    Webster, L
    Chignell, AH
    Charteris, DG
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) : 1091 - 1096
  • [12] Intravitreal Ranibizumab Combined with Panretinal Photocoagulation in Patients with Treatment-Naive Proliferative Diabetic Retinopathy
    Ferraz, Daniel
    Sophie, Raafay
    Bittencourt, Millena
    Preti, Rony
    Vazquez, Lisa
    Motta, Augusto
    Hanout, Mostafa
    Sepah, Yasir
    Quan Dong Nguyen
    Takahashi, Walter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [13] Increased Expression of Periostin in Vitreous and Fibrovascular Membranes Obtained from Patients with Proliferative Diabetic Retinopathy
    Yoshida, Shigeo
    Ishikawa, Keijiro
    Asato, Ryo
    Arima, Mitsuru
    Sassa, Yukio
    Yoshida, Ayako
    Yoshikawa, Hiroshi
    Narukawa, Keisuke
    Obika, Satoshi
    Ono, Junya
    Ohta, Shoichiro
    Izuhara, Kenji
    Kono, Toshihiro
    Ishibashi, Tatsuro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (08) : 5670 - 5678
  • [14] Microarray Analysis of Gene Expression in Fibrovascular Membranes Excised From Patients With Proliferative Diabetic Retinopathy
    Ishikawa, Keijiro
    Yoshida, Shigeo
    Kobayashi, Yoshiyuki
    Zhou, Yedi
    Nakama, Takahito
    Nakao, Shintaro
    Sassa, Yukio
    Oshima, Yuji
    Niiro, Hiroaki
    Akashi, Koichi
    Kono, Toshihiro
    Ishibashi, Tatsuro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (02) : 932 - 946
  • [15] Efficacy comparison of intravitreal injections of conbercept and ranibizumab for severe proliferative diabetic retinopathy
    Lu, Qianyi
    Lu, Li
    Chen, Bin
    Chen, Wei
    Lu, PeiRong
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2019, 54 (03): : 291 - 296
  • [16] Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy
    Lin, James
    Chang, Jonathan S.
    Smiddy, William E.
    OPHTHALMOLOGY, 2016, 123 (09) : 1912 - 1918
  • [17] Differential distribution of fibrovascular proliferative membranes in 25-gauge vitrectomy for proliferative diabetic retinopathy
    Lu, Nan
    Yang, Shi-Lin
    Guo, Shuo
    Yang, Dong-Ni
    Liu, Li
    Fan, Chun-Hui
    Guo, Ying
    Liu, Jian
    Zhao, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (08) : 1462 - 1468
  • [18] Improvement of diabetic retinopathy with intravitreal Ranibizumab
    Kernt, Marcus
    Cserhati, Sarah
    Seidensticker, Florian
    Liegl, Raffael
    Kampik, Anselm
    Neubauer, Aljoscha
    Ulbig, Michael W.
    Reznicek, Lukas
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2013, 100 (01) : E11 - E13
  • [19] ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy
    Barroso, Rafael de Montier P.
    Messias, Katharina
    Garcia, Denny Marcos
    Cardillo, Jose Augusto
    Scott, Ingrid U.
    Messias, Andre
    Jorge, Rodrigo
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2020, 83 (06) : 526 - 534
  • [20] Intravitreous ranibizumab for proliferative diabetic retinopathy
    Jonathan M. Gibson
    Samantha McGinnigle
    Nature Reviews Endocrinology, 2016, 12 : 130 - 131